Position in IRWD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,292,977
+$152,193 QoQ
Shares Held
368,370
+8.8% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0.5236582783614301.ToString("F0")%
Shared 39.378613893639546.ToString("F0")%
None 60.09772782799902.ToString("F0")%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cerity Partners LLC holds $73,705,978 across 27 Drug Manufacturers - Specialty & Generic names. IRWD ranks #10 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
144,529 | $19,040,248 | |
| 2 | ZTS |
Zoetis Inc.
|
127,682 | $15,093,288 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
24,368 | $14,449,735 | |
| 4 | HLN |
Haleon plc
|
459,205 | $4,596,640 | |
| 5 | VTRS |
Viatris Inc
|
306,139 | $4,135,936 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
85,414 | $2,572,668 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
136,388 | $2,525,904 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
181,595 | $2,515,090 |
All Filings in IRWD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,292,977 | 368,370 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,140,784 | 338,512 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $444,152 | 339,048 | Shares | Other | 2025-10-22 | |
| 2025-06-30 | $244,576 | 339,689 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $141,822 | 96,478 | Shares | Sole | 2025-04-30 | |
| 2024-03-31 | $91,324 | 10,485 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||